[1] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315.[2] Sasportas LS, Kasmieh R, Wakimoto H, et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA.2009; 106: 4822-4827.[3] Sonabend AM, Ulasov IV, Tyler MA,et al. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells.2008;26: 831-841.[4] Yang B, Wu X, Mao Y,et al. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery. 2009; 65: 610-624; discussion 624.[5] Karnoub AE, Dash AB, Vo AP,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature.2007;449:557-563.[6] Liu S, Ginestier C, Ou SJ,et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res.2011;71:614-624. [7] Goldstein RH, Reagan MR, Anderson K,et al. Human bone marrowderived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 2010;70: 10044-10050.[8] Menon LG, Picinich S, Koneru R, et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007; 25: 520-528.[9] Komarova S, Roth J, Alvarez R,et al. Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor. J Ovarian Res.2010;3:12.[10] Loebinger MR, Kyrtatos PG, Turmaine M,et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res.2009; 69: 8862-8867.[11] Gao H, Priebe W, Glod J,et al. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cellderived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells.2009;27:857-865.[12] Klopp AH, Spaeth EL, Dembinski JL,et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res.2007;67: 11687-11695.[13] Potapova IA, Brink PR, Cohen IS,et al.Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem.2008;283: 13100-13107.[14] Rüster B,Göttig S,Ludwig RJ,et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells.Blood.2006;108:3938-3944. [15] Kidd S, Caldwell L, Dietrich M,et al.Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an eff ect countered by anti-infl ammatory treatment. Cytotherapy.2010;12:615-625.[16] Ramasamy R, Lam EW-F, Soeiro I,et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia.2007;21:304-310.[17] Corcoran KE, Trzaska KA, Fernandes H,et al. Mesenchymal stemcells in early entry of breast cancer into bone marrow. PloS One.2008;3:e2563.[18] Qiao L, Xu ZL, Zhao TJ,et al. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett.2008;269:67-77.[19] Zhu W, Xu W, Jiang R,et al. Mesenchymal stem cells derived frombone marrow favor tumor cell growth in vivo. Exp Mol Pathol.2006;80:267-274.[20] Ame-Thomas P, Maby-El Hajjami H, Monvoisin C,et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2007;109:693-702.[21] Muehlberg F, Song YH, Krohn A,et al. Tissue resident stem cells promote breast cancer growth and metastasis. Carcinogenesis.2009;30:589-597. [22] Muehlberg FL, Song YH, Krohn A et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009; 30:589-597.[23] Yu JM, Jun ES, Bae YC,et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev.2008;17:463-473.[24] Khakoo AY, Pati S, Anderson SA, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma. J Exp Med. 2006;203:1235-1247.[25] Qiao L, Xu Z, Zhao T,et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res.2008;18: 500-507.[26] Zhu Y, Sun Z, Han Q et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia. 2009;23: 925-933. [27] Cousin B, Ravet E, Poglio S et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. Plos One.2009;4:e6278.[28] Cho JA, Park H, Kim HK,et al. Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer 2009;115:311-323.[29] Corsten MF, Shah K. Therapeutic stem-cells for cancer treatment: Hopes and hurdles in tactical warfare. Lancet Oncol.2008;9:376-384.[30] Hall B, Dembinski J, Sasser AK,et al. Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol. 2007;86:8-16.[31] Nakamizo A, Marini F, Amano T,et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res.2005;65:3307-3318.[32] Loebinger MR, Eddaoudi A, Davies D,et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res.2009; 69:4134-4142.[33] Wang N, Fallavollita L, Nguyen L,et al. Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Mol Ther.2009;17:1241-1249.[34] Ren C,Kumar S,Chanda D,et al. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem cells.2008; 26:2332-2338.[35] Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res.2005;65:3307-3318.[36] Ren C,Kumar S,Chanda D,et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.Gene Ther. 2008;15:1446-1453.[37] Li X,Lu Y,Huang W,et al.In vitro effect of adenovirus-mediated human gamma interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematol Oncol.2006;24:151-158.[38] Mohr A, Lyons M, Deedigan L,et al. Mesenchymal Stem Cells expressing TRAIL lead to tumour growth inhibition in an experimentallung cancer model. J Cell Mol Med.2008; 12: 2628-2643.[39] Lata GM,Kathleen K,Hong WY,et al. Human Bone Marrow-Derived Mesenchymal Stromal Cells Expressing S-TRAIL as a Cellular Delivery Vehicle for Human Glioma Therapy. Stem Cells.2009;27:2320-2330.[40] Seong MK,Ji HO,Soon AP,et al. Irradiation Enhances the Tumor Tropism and Therapeutic Potential of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Glioma Therapy. Stem Cells.2010;28:2217-2228.[41] Nakamura K, Ito Y, Kawano Y,et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther.2004;11:1155-1164.[42] Gao P,Ding Q,Wu Z,et al.Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett. 2010; 290:157-166.[43] Xu G, Jiang XD, Xu Y, et al. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol Int.2009;33(4):466-474.[44] Xin H, Kanehira M, Mizuguchi H,et al. Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. StemCells.2007;25:1618-1626.[45] Dwyer RM, Ryan J, Havelin RJ, et al. Mesenchymal Stem Cell-Mediated Delivery of the Sodium Iodide Symporter Supports Radionuclide Imaging and Treatment of Breast Cancer. Stem Cells.2011;29:1149-1157.[46] Kucerova L, Altanerova V, Matuskova M,et al. Adipose tissuederived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007;67: 6304-6313.[47] Kucerova L, Matuskova M, Pastorakova A,et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med.2008;10:1071-1082.[48] Uchibori R,Okada T,Ito T,et al.Retroviral vector–producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med.2009;11:373-381.[49] Stoff-Khalili MA,Rivera AA,Mathis JM,et al.Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.Breast Cancer Res Treat. 2007;105:157-167.[50] Komarova S, Kawakami Y, Stoff-Khalili MA,et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther. 2006;5:755-766. |